Periodic Reporting for period 2 - NEWCARBOVAX (New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism)

Glycoconjugates are among the safest and most efficacious vaccines developed against infectious diseases. They have been developed to improve the immunogenicity of polysaccharide vaccines which are T cell independent, poorly immunogenic in infants and young children < 2 years...